Immunogenicity, safety, and effectiveness of influenza vaccine among subject at high risk

Immunogenicity, safety, and effectiveness of influenza vaccine among subject at high risk - Immunogenicity, safety, and effectiveness of influenza vaccine among subject with severe motor and intellectual disability

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015037

Enrollment

100

Registered

2014-09-03

Start date

2006-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects with disability or their guardians provided written informed consent for their participation in this study

Exclusion criteria

Exclusion criteria: Exclusion criteria were follows: if they had any history of diphtheria, tetanus, and pertussis; if they had received any other drug or vaccine within 30 days of entry; if they had a history of allergic reactions to any vaccine component; if they had an acute disease or a febrile illness at the time of vaccination.

Design outcomes

Primary

Measure	Time frame
Immune response rates at 4 weeks after vaccination	—

Secondary

Measure	Time frame
Antibody efficacy	—

Countries

Japan

Contacts

Public ContactMegumi Hara

Saga University Department of Medicine

harameg@cc.saga-u.ac.jp0952-34-2289

Outcome results